Preventogen: A proven microbicidal agent

In vitro lab data

BACTERIA

Acinetobacter baumanii (multi-antibiotic resistant)

Campylobacter jejuni (drug-resistant)

Clostridioides difficile

Carbapenem-resistant Enterobacter cloacae

Enterococcus faecalis (drug-resistant)

Escherichia coli

MRSA: Methicillin-resistant Staphylococcus aureus

Mycobacterium avium

Neisseria gonorrhoeae (drug-resistant)

Pseudomonas aeruginosa

Shigella flexneri

Staphylococcus aureus

Streptococcus pneumoniae (drug-resistant)

Streptococcus pyogenes

VRE: Vancomycin-resistant Enterococci

FUNGI

Aspergillus brasiliensis

Candida albicans (drug-resistant)

Candida auris (antibiotic resistant)

Trichophyton mentagrophytes

Trichophyton rubrum

VIRUS

Herpes Simplex Virus Type 1

Monkeypox Virus (USA-2003)

Varicella Zoster Virus

Serious or Urgent threats as cited in the CDC’s Antibiotic Resistance Threats in the United States, 2019

Newest data

In-vitro time-kill results

These results are also available as a PDF download. If you are viewing this table on a mobile device, try using landscape mode for a better experience.
MICROORGANISM SPECIES
(ATCC OR BSLI #)
EXPOSURE TIMELOG10 REDUCTIONPERCENT REDUCTION
Acinetobacter baumanii10
(ATCC #BAA-1605)
30 seconds5.0599.99%
60 seconds5.0599.99%
120 seconds5.0599.99%
Campylobacter jejuni10
(ATCC #BAA-373)
30 seconds3.1099.92%
60 seconds3.1099.92%
120 seconds3.1099.92%
Clostridioides difficile10
(ATCC #9689)
30 seconds2.4999.68%
60 seconds2.6099.75%
120 seconds2.5299.70%
Enterobacter cloacae10
(ATCC #BAA-2341)
30 seconds5.3499.99%
60 seconds5.3499.99%
120 seconds5.3499.99%
Mycobacterium avium10
(ATCC #700897)
30 seconds6.4999.99%
60 seconds6.4999.99%
120 seconds6.4999.99%
Neisseria gonorrhoeae10
(ATCC #BAA-1846)
30 seconds3.9399.99%
60 seconds3.9399.99%
120 seconds3.9399.99%
Shigella flexneri10
(BSLI #080718Sfl)
30 seconds5.2699.99%
60 seconds5.2699.99%
120 seconds5.2699.99%
Streptococcus pneumoniae10
(ATCC #700904)
30 seconds5.7999.99%
60 seconds5.7999.99%
120 seconds5.7999.99%
Monkeypox Virus strain USA-20039
(BEI Resources #NR-2500)
30 seconds3.2599.94%
60 seconds3.2599.94%
120 seconds3.2599.94%
Candida auris8
(AR-Bank #0390)
antibiotic resistant strain
30 seconds5.6199.99%
90 seconds5.6199.99%
120 seconds5.6199.99%
Aspergillus brasiliensis5
(ATCC #16404)
14 days3.923099.9881%
28 days3.923099.9881%
Candida albicans5
(ATCC #10231)
14 days5.159199.9993%
28 days5.159199.9993%
Escherichia coli5
(ATCC #8739)
14 days4.204199.9938%
28 days4.204199.9938%
Pseudomonas aeruginosa5
(ATCC #9027)
14 days4.107299.9922%
28 days4.107299.9922%
Staphylococcus aureus5
(ATCC #6538)
14 days4.716099.9981%
28 days4.716099.9981%
Herpes Simplex Virus Type 14
(ATCC #VR-260)
30 seconds5.00>99.99%
90 seconds5.00>99.99%
120 seconds5.00>99.99%
Varicella Zoster Virus4
(ATCC #VR-1367)
30 seconds4.0099.99%
90 seconds4.0099.99%
120 seconds4.0099.99%
  1. Robins et al, (2008), The Effectiveness of Liquid Bandage as an Adhesive and Antimicrobial Agent. Journal of Drugs and Dermatology, 2008 Aug;7(8):764-6. PMID: 18720693.
  2. Study: 918905 (2013), ASTM E-2315. Testing facility: WuXiTec, Marietta, Georgia USA
  3. Study: 919536 (2013), ASTM E-2315. Testing facility: WuXiTec, Marietta, Georgia USA
  4. Study: 150978-402 (2015), A GLP EVALUATION OF ONE TEST PRODUCT FOR ITS VIRUCIDAL PROPERTIES FOLLOWING THE ASTM E-1052-11 IN-VITRO VIRUCIDAL SUSPENSION METHOD. Testing facility: BIOSCIENCE LABORATORIES, INC, Bozeman, Montana USA
  5. Study: 160297-203 (2016), ANTIMICROBIAL PRESERVATIVES EFFECTIVENESS EVALUATION OF ONE PRODUCT WHEN CHALLENGED WITH FIVE MICROORGANISM SPECIES. Testing facility: BIOSCIENCE LABORATORIES, INC, Bozeman, Montana USA
  6. Study: 151128-150 (2016), CLINICAL DETERMINATION OF THE ANTIFUNGAL EFFICACY OF ONE TEST PRODUCT WITH TWO COMPARATOR PRODUCTS FOLLOWING THE ASTM E2613 STANDARDIZED TEST METHOD. Testing facility: BIOSCIENCE LABORATORIES, INC, Bozeman, Montana USA
  7. Study: 151073-407 (2016), EVALUATION OF ONE FORMULATION WHEN APPLIED A WOUNDED FULL THICKNESS TISSUE MODEL IN TWO DIFFERENT METHODS OF APPLICATION TO EVALUATE ANTIMICROBIAL ACTIVITY. Testing facility: BIOSCIENCE LABORATORIES, INC, Bozeman, Montana USA
  8. Study: 1904161-201 (2019), AN IN-VITRO TIME-KILL EVALUATION OF ONE TEST PRODUCT WHEN CHALLENGED WITH CANDIDA AURIS. Testing facility: BIOSCIENCE LABORATORIES, INC, Bozeman, Montana USA
  9. Study: 2208409-408 (2022), EVALUATION OF ONE TEST PRODUCT FOR ITS VIRUCIDAL PROPERTIES BASED UPON THE ASTM El052-20 METHOD. Testing facility: NELSON LABORATORIES BOZEMAN, LLC, Bozeman, Montana USA
  10. Study: 2208408-201 (2023), A GLP IN-VITRO TIME-KILL EVALUATION BASED UPON ASTM METHOD E2783-22. Testing facility: NELSON LABORATORIES BOZEMAN, LLC, Bozeman, Montana USA